Bioharvest Sciences (BHST) Payables (2023 - 2025)

Bioharvest Sciences has reported Payables over the past 3 years, most recently at $2.8 million for Q4 2025.

  • Quarterly results put Payables at $2.8 million for Q4 2025, down 62.64% from a year ago — trailing twelve months through Dec 2025 was $2.8 million (down 62.64% YoY), and the annual figure for FY2025 was $2.8 million, down 62.64%.
  • Payables for Q4 2025 was $2.8 million at Bioharvest Sciences, down from $7.4 million in the prior quarter.
  • Over the last five years, Payables for BHST hit a ceiling of $7.4 million in Q4 2024 and a floor of $1.8 million in Q4 2023.
  • Median Payables over the past 3 years was $2.8 million (2025), compared with a mean of $4.0 million.
  • Biggest five-year swings in Payables: soared 317.89% in 2024 and later crashed 62.64% in 2025.
  • Bioharvest Sciences' Payables stood at $1.8 million in 2023, then soared by 317.89% to $7.4 million in 2024, then crashed by 62.64% to $2.8 million in 2025.
  • The last three reported values for Payables were $2.8 million (Q4 2025), $7.4 million (Q4 2024), and $1.8 million (Q4 2023) per Business Quant data.